Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to NON-HODGKIN LYMPHOMA (NHL)

Oncology News Central (ONC)

Newly Defined High-Risk MCL Subgroup Has “Dismal” Outcomes

Hematology/Oncology August 21st 2023

The New England Journal of Medicine

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

Hematology/Oncology July 25th 2023

Cancer Therapy Advisor

Epkinly Approved for Relapsed, Refractory Diffuse Large B-Cell Lymphoma

Hematology/Oncology June 27th 2023

Clinical Advances in Hematology & Oncology

Key Points From the SHINE Trial in Mantle Cell Lymphoma

Hematology November 14th 2022

Clinical Advances in Hematology & Oncology

CAR T-Cell Therapy for Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL): A Comprehensive Review

Hematology/Oncology May 25th 2022

Cancer Therapy Advisor

Moderna COVID-19 Vaccine May Be More Effective in CLL Patients

Hematology/Oncology April 12th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form